Results 151 to 160 of about 29,831 (202)

A Framework for Understanding How and Why Animals Die

open access: yesEcology Letters, Volume 29, Issue 11, November 2026.
Conceptual web linking potential drivers (whys) of mortality to proximate causes of death (hows). Environmental and ecological drivers influence mortality indirectly through interacting, intermediate whys such as movement, body condition, disease and life history state, culminating in diverse proximate causes of death.
Roxanne S. Beltran   +3 more
wiley   +1 more source

Oral Chemical Burn Due to Occupational Exposure to Potassium Hydroxide: An Unusual Case Report

open access: yesSpecial Care in Dentistry, Volume 46, Issue 6, November/December 2026.
ABSTRACT Objective To report an uncommon case of oral chemical burn caused by occupational exposure to potassium hydroxide (KOH) managed with photobiomodulation (PBM). Case Report A 50‐year‐old man experienced occupational exposure to KOH while working in a food factory. The accident occurred during maintenance of a pipeline that should have been empty;
Camila Barcellos Calderipe   +7 more
wiley   +1 more source

4‐Thiazolidinone/2,4‐Thiazolidinedione–Sulfonamide Hybrids: A Concise Review of Their Design and Pharmacological Significance

open access: yesChemMedChem, Volume 21, Issue 20, 28 October 2026.
Sulfonamide–thiazolidinone hybrids integrate complementary pharmacophores to generate multifunctional scaffolds with broad pharmacological potential. Their structural versatility supports antimicrobial, antifungal, antioxidant, anticancer, anti‐inflammatory, antidiabetic, anticonvulsant, and enzyme‐inhibitory activities.
Subham Kumar Vishwakarma   +6 more
wiley   +1 more source
Some of the next articles are maybe not open access.

Related searches:

Investigation of the immunogenicity of diclofenac and diclofenac metabolites

Toxicology Letters, 2007
Oral administration of the non-steroidal anti-inflammatory drug diclofenac (DCF) is associated with a high incidence of adverse drug reactions, some of which are thought to be mediated by the immune system. It has been proposed that metabolic activation of DCF and covalent binding to protein generates an antigenic determinant that stimulates immune ...
Dean J, Naisbitt   +5 more
openaire   +2 more sources

Diclofenac hepatitis

Australian and New Zealand Journal of Medicine, 1991
AbstractWe report five cases of biopsy‐proven hepatitis developing between six and 20 weeks after administration of diclofenac. In one patient jaundice had previously developed following use of ibuprofen. In another the clinical, biochemical and histopathological features were those of chronic active hepatitis and treatment with corticosteroids was ...
R W, Sallie   +4 more
openaire   +2 more sources

The history of diclofenac

Seminars in Arthritis and Rheumatism, 1985
The purpose in developing diclofenac sodium was to synthesize a nonsteroidal anti-inflammatory drug with high activity and outstanding tolerability. Factors considered were drug transport through biologic membranes, the atomic and spatial structure of the molecule, and the electronic structure.
openaire   +3 more sources

Diclofenac

Reactions Weekly, 2021
openaire   +2 more sources

Diclofenac

Reactions Weekly, 2022
openaire   +2 more sources

Diclofenac see Aspirin/diclofenac

Reactions Weekly, 1991
openaire   +1 more source

Home - About - Disclaimer - Privacy